- Home
- ITOS vs GAIN Comparison
ITOS vs GAIN Comparison
Compare ITOS & GAIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITOS
- GAIN
- Stock Information
- Founded
- ITOS 2011
- GAIN 2005
- Country
- ITOS United States
- GAIN United States
- Employees
- ITOS N/A
- GAIN N/A
- Industry
- ITOS Biotechnology: Biological Products (No Diagnostic Substances)
- GAIN Finance: Consumer Services
- Sector
- ITOS Health Care
- GAIN Finance
- Exchange
- ITOS Nasdaq
- GAIN Nasdaq
- Market Cap
- ITOS 450.9M
- GAIN 522.8M
- IPO Year
- ITOS 2020
- GAIN 2005
- Fundamental
- Price
- ITOS N/A
- GAIN $14.21
- Analyst Decision
- ITOS Hold
- GAIN Buy
- Analyst Count
- ITOS 6
- GAIN 2
- Target Price
- ITOS $10.40
- GAIN $14.00
- AVG Volume (30 Days)
- ITOS 1.6M
- GAIN 139.1K
- Earning Date
- ITOS 08-06-2025
- GAIN 11-06-2025
- Dividend Yield
- ITOS N/A
- GAIN 15.48%
- EPS Growth
- ITOS N/A
- GAIN 8.96
- EPS
- ITOS N/A
- GAIN 2.16
- Revenue
- ITOS N/A
- GAIN $95,028,000.00
- Revenue This Year
- ITOS N/A
- GAIN $6.70
- Revenue Next Year
- ITOS N/A
- GAIN $5.50
- P/E Ratio
- ITOS N/A
- GAIN $6.57
- Revenue Growth
- ITOS 177.89
- GAIN 6.55
- 52 Week Low
- ITOS $4.80
- GAIN $11.42
- 52 Week High
- ITOS $17.63
- GAIN $15.34
- Technical
- Relative Strength Index (RSI)
- ITOS 1.63
- GAIN 54.28
- Support Level
- ITOS $10.10
- GAIN $13.92
- Resistance Level
- ITOS $10.17
- GAIN $14.20
- Average True Range (ATR)
- ITOS 0.03
- GAIN 0.16
- MACD
- ITOS -1.20
- GAIN 0.00
- Stochastic Oscillator
- ITOS 0.00
- GAIN 60.42
About ITOS iTeos Therapeutics Inc.
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.
About GAIN Gladstone Investment Corporation Business Development Company
Gladstone Investment Corp operates as an externally managed, closed-end, non-diversified management investment company. Its objective is to invest in debt and equity securities of established private businesses operating in the U.S. and to achieve and grow current income by investing in debt securities of established businesses; provide the stockholders with long-term capital appreciation in the value of its assets by investing in equity securities of established businesses. It focuses on investing in lower-middle-market private businesses.